Abstract | BACKGROUND: OBJECTIVES: To examine TDP-43 in cerebrospinal fluid (CSF) and to analyze whether it could serve as a diagnostic marker. DESIGN: We characterized CSF TDP-43 by immunoblot using different TDP-43 antibodies and determined the relative TDP-43 levels in CSF samples from patients. SETTING: Academic research. PATIENTS: Twelve patients with FTLD, 15 patients with ALS, 9 patients with ALS plus FTLD, 3 patients with ALS plus additional signs of frontal disinhibition, and 13 control subjects. MAIN OUTCOME MEASURES: Results of TDP-43 immunoblot. RESULTS: Polyclonal TDP-43 antibodies recognized a 45-kDa band in all analyzed samples. Two monoclonal and N-terminus-specific antibodies did not detect any specific bands, but C-terminus-specific antibodies detected a 45-kDa band and additional bands at approximately 20 kDa in all CSF samples. Relative quantification of 45-kDa bands revealed significant differences among the diagnostic groups (P =.046). Specifically, patients with ALS (P =.03) and FTLD (P =.02) had higher TDP-43 levels than controls but with a prominent overlap of values. CONCLUSION: Although there is no evidence of pathologically altered TDP-43 proteins in CSF, TDP-43 levels in CSF might aid in characterizing subgroups of patients across the ALS and FTLD disease spectrum.
|
Authors | Petra Steinacker, Corinna Hendrich, Anne D Sperfeld, Sarah Jesse, Christine A F von Arnim, Stefan Lehnert, Alice Pabst, Ingo Uttner, Hayrettin Tumani, Virginia M-Y Lee, John Q Trojanowski, Hans A Kretzschmar, Albert Ludolph, Manuela Neumann, Markus Otto |
Journal | Archives of neurology
(Arch Neurol)
Vol. 65
Issue 11
Pg. 1481-7
(Nov 2008)
ISSN: 1538-3687 [Electronic] United States |
PMID | 19001167
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- DNA-Binding Proteins
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Amyotrophic Lateral Sclerosis
(cerebrospinal fluid, complications, diagnosis, psychology)
- Biomarkers
(cerebrospinal fluid)
- DNA-Binding Proteins
(cerebrospinal fluid)
- Dementia
(cerebrospinal fluid, complications, diagnosis)
- Female
- Humans
- Immunoblotting
- Male
- Middle Aged
|